Harvard Medical School’s McLean Hospital Institutional Review Board (IRB) met to review the MAPS-sponsored pilot study designed to explore the use of MDMA-assisted psychotherapy in subjects with anxiety associated with advanced cancer, to be directed by co-investigators Dr. John Halpern, Dr. Todd Shuster, Dr. Umadevi Naidoo, and Dr. Arthur Siegel. The protocol was…approved! The only conditions were that that the approval was subject to FDA and DEA approval, and we were requested to shorten (!) the informed consent form.
